SCHEMBL4814918

SCHEMBL4814918

COc1cc(C(=O)OCc2ccccc2)ccc1-c1cc(C)c(OCCN[C@@H](C)[C@@H](O)c2ccc(OCc3ccccc3)c(NS(C)(=O)=O)c2)c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ F2 P00734 1/20 0.37
▸ F10 P00742 1/20 0.37
▸ PRSS1 P07477 1/20 0.37
▸ F7 P08709 1/20 0.37
▸ PDE4A P27815 2/20 0.37
▸ PDE4B Q07343 2/20 0.37
▸ PDE4C Q08493 2/20 0.37
▸ PDE4D Q08499 2/20 0.37
▸ ADRB3 P13945 7/20 0.37
▸ ADRA1D P25100 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ ADRA1B P35368 1/20 0.36
▸ SMPD1 P17405 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4814901 1.00 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2MEN1KMT2AF2
SCHEMBL4811685 0.90 ADRB3 (0.40) ALDH1A1SMN1; SMN2MEN1KMT2AF2
SCHEMBL4811697 0.90 ADRB3 (0.40) ALDH1A1SMN1; SMN2MEN1KMT2AF2
SCHEMBL4815105 0.90 ADRB3 (0.39) PDE4APDE4BPDE4CPDE4DADRB3
SCHEMBL4815109 0.90 ADRB3 (0.39) PDE4APDE4BPDE4CPDE4DADRB3
SCHEMBL4814529 0.89 MRGPRX4 (0.38) ALDH1A1SMN1; SMN2MEN1KMT2APDE4A
SCHEMBL4814553 0.89 MRGPRX4 (0.38) ALDH1A1SMN1; SMN2MEN1KMT2APDE4A
SCHEMBL4814502 0.87 ADRB3 (0.39) PDE4APDE4BPDE4CPDE4DADRB3
SCHEMBL4814509 0.87 ADRB3 (0.39) PDE4APDE4BPDE4CPDE4DADRB3
SCHEMBL5699514 0.85 ADRA1D (0.39) ALDH1A1SMN1; SMN2MEN1KMT2AF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7417169-B2 Amino alcohol derivatives, medicinal composition containing the same, and use of these KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-08-26 — — US disclosed
US-20070078184-A1 Amino alcohol derivatives, medicinal composition containing the same, and use of these KISSEI PHARMACEUTICAL CO., LTD. (JP) 2007-04-05 — — US disclosed
EP-1679304-A1 AMINO ALCOHOL DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USE OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-07-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078184-A1 Amino alcohol derivatives, medicinal composition containing the same, and use of these ADRB2, ADRA2A, ADRA1A ALDH1A1 106/4885SMN1; SMN2 4525/4885MEN1 4166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback